01 1Synthon Pharmaceuticals
01 1AXITINIB
01 1Netherlands
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-06-27
Pay. Date : 2023-02-06
DMF Number : 37971
Submission : 2023-02-02
Status : Active
Type : II
20
Synthon Bv, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is AXITINIB, with a corresponding US DMF Number 37971.
Remarkably, this DMF maintains an Active status since its submission on February 02, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 27, 2023, and payment made on February 06, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
